Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000375344

Medchemexpress LLC Larotinib mesylate hydrate | 2097129-93-4 | C26H36ClFN4O11S2 | 25 MG
SDP

Catalog No. 5000375344
Encompass_Preferred

Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM.

  • Potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI)
  • Primary target is EGFR with an IC50 of 0.6 nM
  • Purity of 98.66%
  • Appears as a white to off-white solid
  • Demonstrates dose-dependent antitumor results in vivo
  • Achieves a tumor-inhibiting rate exceeding 60% in tumor-bearing mice models

Catalog No. 50-003-75344 Supplier Medchemexpress LLC Supplier No. 25MGHY153110A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM.

  • Potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI)
  • Primary target is EGFR with an IC50 of 0.6 nM
  • Purity of 98.66%
  • Appears as a white to off-white solid
  • Demonstrates dose-dependent antitumor results in vivo
  • Achieves a tumor-inhibiting rate exceeding 60% in tumor-bearing mice models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.